China Life Insurance Gains NFRA Approval for Employee Representative Director

An update from China Life Insurance Co ( (HK:2628) ) is now available.

China Life Insurance Company Limited announced that China’s National Financial Regulatory Administration has approved the qualification of Li Wei as an Employee Representative Director on its eighth board of directors. His term of service began on 11 March 2026, further formalizing the company’s board composition and reinforcing employee representation in its corporate governance structure.

The board now comprises executive, non-executive, independent non-executive, and employee representative directors, with Li Wei formally joining as the designated employee representative. This regulatory approval underscores compliance with Chinese financial governance requirements and may enhance stakeholder confidence in the company’s board oversight and alignment with staff interests.

The most recent analyst rating on (HK:2628) stock is a Buy with a HK$40.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.

More about China Life Insurance Co

China Life Insurance Company Limited is a leading life insurer in mainland China, operating as a joint stock limited company with shares listed in Hong Kong. The company focuses on life insurance and related financial protection products, serving a broad base of policyholders as part of China’s core state-linked financial services sector.

Average Trading Volume: 65,097,711

Technical Sentiment Signal: Buy

Current Market Cap: HK$1238.7B

Find detailed analytics on 2628 stock on TipRanks’ Stock Analysis page.